We found significantly increased levels of FGA, FGB, FGG, HP and HPX in AD control, which were significantly diminished in response to 5% GP supplementation except for HP which showed a decreasing trend (Figures 6C, D). The gene discussed is HP; the disease is Alzheimer disease.